[
  {
    "ts": "2025-11-16T01:05:31+00:00",
    "headline": "What Boston Scientific (BSX)'s Surging Sales and Siemens Partnership Mean for Shareholders",
    "summary": "Boston Scientific recently reported strong quarterly results, surpassing expectations with 21.4% organic sales growth and raising its full-year 2025 outlook for both revenue and adjusted earnings per share. The company also announced an exclusive distribution agreement for the AcuNav 4D ICE catheter with Siemens Healthineers, aimed at supporting the expansion of its Watchman business and procedural adoption. We'll examine how Boston Scientific's improved financial outlook and new partnership...",
    "url": "https://finance.yahoo.com/news/boston-scientific-bsx-surging-sales-010531075.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "c474c5e9-7141-34a1-87c7-2a1584c366bd",
      "content": {
        "id": "c474c5e9-7141-34a1-87c7-2a1584c366bd",
        "contentType": "STORY",
        "title": "What Boston Scientific (BSX)'s Surging Sales and Siemens Partnership Mean for Shareholders",
        "description": "",
        "summary": "Boston Scientific recently reported strong quarterly results, surpassing expectations with 21.4% organic sales growth and raising its full-year 2025 outlook for both revenue and adjusted earnings per share. The company also announced an exclusive distribution agreement for the AcuNav 4D ICE catheter with Siemens Healthineers, aimed at supporting the expansion of its Watchman business and procedural adoption. We'll examine how Boston Scientific's improved financial outlook and new partnership...",
        "pubDate": "2025-11-16T01:05:31Z",
        "displayTime": "2025-11-16T01:05:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sFax.1EIpS7VVYvaDN0jRw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OB69YGFZw788CGHTsahrkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f07ef6f3ab742340c5e8f39cd1ee19ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-surging-sales-010531075.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/boston-scientific-bsx-surging-sales-010531075.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "SHL.DE"
            },
            {
              "symbol": "SIE.DE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]